

Download the PSMID press statement in response to the return to work comment of Mr. Joey Concepcion here.
Download the PCP and PSMID position statement on rapid antibody tests for COVID-19 here.
PSMID would like to express its strong statement against the use of CHLOROQUINE or HYDROXCHLOROQUINE should not be used for prophylaxis.
There is no high quality evidence that these will prevent COVID19. These drugs should be used cautiously because of the possible side effects.
LET’S NOT TAKE AWAY STOCKS OF CHLOROQUINE FROM THOSE WHO REALLY NEED IT!
Outbreak of Pneumonia caused by a Novel Coronavirus (COVID-19) Interim Health Advisory and Position Statement from the Philippine Society for Microbiology and Infectious Diseases, Pediatric Infectious Diseases Society of the Philippines, Philippine College of Physicians, and Philippine Medical Association.
Dr. Jemelyn Garcia, FPCP, FPSMID
Dr. Maria Sonia Salamat, FPCP, FPSMID
Dr. Marja B. Buensalido, FPCP, FPSMID
Dr. Emmerson Gale Vista, FPDS
Dr. Clarisse Garcia-Mendoza, FPDS
Dr. Kingbherly L. Li, FPCP, FPSMID
Dr. Yvette Silubrico, FPCP, FPSMID
Dr. Chatie Olasiman, FPCP, FPSMID
Dr. Ma. Charmian Hufano, FPCP, FPSMID
Dr. Mitzie Lou Osabel, FPCP, FPSMID
Dr. Janice C. Caoili, FPCP, FPSMID
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.